DISCLOSEDT+30
Nippon India Pharma Fund
Suraksha Diagnostic Limited · NSE
38,96,349 sh · ₹138.48 Cr
Filed 30 Sept 2026AMFI portfolioview source
Nippon India Pharma Fund
1.5% of their portfolio
₹138.48 Cr
38,96,349 sh
Aditya Birla Sun Life ELSS Tax Saver Fund
0.3% of their portfolio
₹44.76 Cr
16,39,777 sh
Aditya Birla Sun Life Pharma & Healthcare Fund
0.9% of their portfolio
₹9.14 Cr
3,34,736 sh
Ritu Mittal
Investor
₹57.71 L
19,130 sh
Aparajita Chatterjee
Investor
₹25.81 L
52,533 sh
Dr. Somnath Chatterjee
Investor
₹24.75 L
39,875 sh
Bipul Mittal
Investor
₹15.91 L
5,800 sh
FIIs trimmed their stake −12.4pp QoQ
Sept 2026 quarter
Ownership by quarter
Promoter
— 0.0pp
Nippon India Pharma Fund
Suraksha Diagnostic Limited · NSE
38,96,349 sh · ₹138.48 Cr
Nippon India Pharma Fund
Suraksha Diagnostic Limited · NSE
38,96,349 sh · ₹131.91 Cr
Nippon India Pharma Fund
Suraksha Diagnostic Limited · NSE
38,96,349 sh · ₹98.25 Cr
Aditya Birla Sun Life ELSS Tax Saver Fund
Suraksha Diagnostic Limited · NSE
16,39,777 sh · ₹44.76 Cr
Nippon India Pharma Fund
Suraksha Diagnostic Limited · NSE
38,96,349 sh · ₹106.35 Cr
Aditya Birla Sun Life Pharma & Healthcare Fund
Suraksha Diagnostic Limited · NSE
3,34,736 sh · ₹9.14 Cr
Nippon India Pharma Fund
Suraksha Diagnostic Limited · NSE
38,96,349 sh · ₹111.36 Cr
Aditya Birla Sun Life Pharma & Healthcare Fund
Suraksha Diagnostic Limited · NSE
3,34,736 sh · ₹9.50 Cr
Aditya Birla Sun Life ELSS Tax Saver Fund
Suraksha Diagnostic Limited · NSE
16,39,777 sh · ₹46.56 Cr
The announcements library is part of Pro.
Every exchange filing this company makes — results, board meetings, dividends, analyst meets, investor presentations — as filed with NSE / BSE, the day it lands.
46 announcements on record for this company.
Promoter holding by quarter: Jun 2025 48.9%, Sep 2025 49.0%, Dec 2025 49.0%, Mar 2026 49.1%, Jun 2026 49.1%. Dec 2024, Mar 2025: no filing.
FII
— 0.0pp
FII holding by quarter: Jun 2025 13.9%, Sep 2025 13.7%, Dec 2025 13.5%, Mar 2026 13.5%, Jun 2026 13.5%. Dec 2024, Mar 2025: no filing.
DII
— +0.1pp
DII holding by quarter: Jun 2025 22.4%, Sep 2025 22.0%, Dec 2025 22.6%, Mar 2026 23.1%, Jun 2026 23.2%. Dec 2024, Mar 2025: no filing.
MF
— +0.3pp
MF holding by quarter: Jun 2025 19.6%, Sep 2025 19.4%, Dec 2025 19.4%, Mar 2026 19.8%, Jun 2026 20.1%. Dec 2024, Mar 2025: no filing.
Per-series scale, bounds labeled. Gaps mark quarters without a filing.
Aparajita Chatterjee
Suraksha Diagnostic Limited · NSE
+9,000 sh · ₹25.81 L
Ownership by quarter
Promoter
— 0.0pp
Promoter holding by quarter: Jun 2025 48.9%, Sep 2025 49.0%, Dec 2025 49.0%, Mar 2026 49.1%, Jun 2026 49.1%. Dec 2024, Mar 2025: no filing.
FII
— 0.0pp
FII holding by quarter: Jun 2025 13.9%, Sep 2025 13.7%, Dec 2025 13.5%, Mar 2026 13.5%, Jun 2026 13.5%. Dec 2024, Mar 2025: no filing.
DII
— +0.1pp
DII holding by quarter: Jun 2025 22.4%, Sep 2025 22.0%, Dec 2025 22.6%, Mar 2026 23.1%, Jun 2026 23.2%. Dec 2024, Mar 2025: no filing.
MF
— +0.3pp
MF holding by quarter: Jun 2025 19.6%, Sep 2025 19.4%, Dec 2025 19.4%, Mar 2026 19.8%, Jun 2026 20.1%. Dec 2024, Mar 2025: no filing.
Per-series scale, bounds labeled. Gaps mark quarters without a filing.
The announcements library is part of Pro.
Every exchange filing this company makes — results, board meetings, dividends, analyst meets, investor presentations — as filed with NSE / BSE, the day it lands.
46 announcements on record for this company.